Screener
Silgan Holdings SLGN Dispensing and Specialty Closures — Total adjusted EBIT
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Silgan Holdings in its filing.
Tagged under the XBRL concept slgn:EarningsBeforeInterestAndTaxesAdjusted.
The source filing: Silgan Holdings’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053967
| Three Months Ended June 30, 2026 | Dispensing and Specialty Closures | Metal Containers | Custom Containers | Corporate | Total |
|---|---|---|---|---|---|
| Net sales | $713,862 | $763,936 | $165,471 | — | $1,643,269 |
| Segment expenses and other (a) | 607,247 | 698,057 | 138,322 | 15,360 | 1,458,986 |
| Equity in earnings of affiliates, net of tax | 982 | — | — | — | 982 |
| Adjusted EBIT | 107,597 | 65,879 | 27,149 | (15,360) | 185,265 |
| Depreciation | 39,266 | 20,260 | 8,022 | 119 | 67,667 |
| Capital expenditures | 36,345 | 21,208 | 6,684 | 7 | 64,244 |
| Three Months Ended June 30, 2025 | |||||
| Net sales | $702,187 | $676,056 | $160,918 | — | $1,539,161 |
Item 1. Financial Statements
FAQ
- What is Silgan Holdings's dispensing and specialty closures — total adjusted EBIT?
- Silgan Holdings (SLGN) reported dispensing and specialty closures — total adjusted EBIT of $107.6M in Q2 2026.
- How has Silgan Holdings's dispensing and specialty closures — total adjusted EBIT changed year-over-year?
- Silgan Holdings's dispensing and specialty closures — total adjusted EBIT decreased by 0.3% year-over-year, from $107.93M to $107.6M.
- What is the long-term trend for Silgan Holdings's dispensing and specialty closures — total adjusted EBIT?
- Over 4 years (2021 to 2025), Silgan Holdings's dispensing and specialty closures — total adjusted EBIT has grown at a 9.2% compound annual growth rate (CAGR), from $295.19M to $419.94M.
- What does dispensing and specialty closures — total adjusted EBIT mean?
- Measures the segment's operating profitability by excluding non-recurring items, restructuring charges, and other adjustments. This metric allows for a normalized view of the segment's core operational performance, facilitating comparisons across different periods. It is a key indicator of the underlying health and cash-generating capability of the business unit.
Ask your AI about Silgan Holdings's dispensing and specialty closures — total adjusted ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude